Subtopic Deep Dive

← Organoselenium and organotellurium chemistry

Organoselenium Toxicology
Research Guide

What is Organoselenium Toxicology?

Organoselenium Toxicology studies the adverse effects, metabolic pathways, and structure-toxicity relationships of organoselenium compounds in biological systems.

This field examines concentration-dependent toxicity, genotoxicity, and hepatotoxicity of organoselenium species like ebselen. Key reviews cover over 300 papers since 2000, with foundational works by Azad and Tomar (2014, 327 citations) and Misra et al. (2015, 303 citations) detailing mechanisms from cell death to therapeutic windows. Research highlights safe dosing for antioxidant applications.

Curated Papers

Key Challenges

Why It Matters

Organoselenium compounds like ebselen show promise as antioxidants but require toxicity profiling for clinical use; Azad and Tomar (2014) map pathways targeted in oxidative stress diseases. Nogueira et al. (2021, 205 citations) update pharmacology to guide safe synthesis of GPx mimetics, preventing overdosing in cancer therapy. Misra et al. (2015) link redox activity to controlled cytotoxicity, enabling translation from lab to therapeutics while minimizing hepatotoxicity risks.

Key Research Challenges

Narrow Therapeutic Index

Organoselenium toxicity occurs at levels slightly above therapeutic doses, complicating dosing; Soriano-García (2004, 213 citations) notes selenocysteine incorporation risks. Balancing antioxidant benefits against cell death requires precise species-dependent profiling (Misra et al., 2015).

Structure-Toxicity Prediction

Predicting genotoxicity and hepatotoxicity from molecular structures remains challenging; Parnham and Sies (2013, 223 citations) detail ebselen's early toxicology gaps. Metabolic transformations vary by compound class, hindering SAR models (Nogueira et al., 2021).

Metabolism-Dependent Effects

Redox cycling leads to unpredictable ROS generation and protein binding; Azad and Tomar (2014) identify pathway targets affected by metabolism. Species-specific selenoprotein interactions demand in vivo validation beyond in vitro assays (Misra et al., 2015).

Essential Papers

Ebselen, a promising antioxidant drug: mechanisms of action and targets of biological pathways

Gajendra Kumar Azad, Raghuvir Singh Tomar · 2014 · Molecular Biology Reports · 327 citations

Redox-Active Selenium Compounds—From Toxicity and Cell Death to Cancer Treatment

Sougat Misra, Mallory Boylan, Arun Kumar Selvam et al. · 2015 · Nutrients · 303 citations

Selenium is generally known as an antioxidant due to its presence in selenoproteins as selenocysteine, but it is also toxic. The toxic effects of selenium are, however, strictly concentration and c...

The early research and development of ebselen

Michael J. Parnham, Helmut Sies · 2013 · Biochemical Pharmacology · 223 citations

Organoselenium Compounds as Potential Therapeutic and Chemopreventive Agents: A Review

M. Soriano-Garcı́a · 2004 · Current Medicinal Chemistry · 213 citations

Selenium is an essential trace element. It is, however toxic at concentration little above which is required for health. Selenium is incorporated into proteins as selenocysteine, the 21(st) amino a...

Toxicology and pharmacology of synthetic organoselenium compounds: an update

Cristina W. Nogueira, Nilda Vargas Barbosa, João Batista Teixeira da Rocha · 2021 · Archives of Toxicology · 205 citations

“The green side of the moon: ecofriendly aspects of organoselenium chemistry”

Stefano Santoro, Juliano B. Azeredo, Vanessa Nascimento et al. · 2014 · RSC Advances · 184 citations

Key aspects for the development of a greener synthesis and the use of the organoselenium compounds.

A glimpse on biological activities of tellurium compounds

Rodrigo L.O.R. Cunha, Iuri E. Gouvêa, Luiz Juliano · 2009 · Anais da Academia Brasileira de Ciências · 180 citations

Tellurium is a rare element which has been regarded as a toxic, non-essential trace element and its biological role is not clearly established to date. Besides of that, the biological effects of el...

Reading Guide

Foundational Papers

Start with Azad and Tomar (2014, 327 citations) for ebselen mechanisms and Parnham and Sies (2013, 223 citations) for development history, as they establish core antioxidant-toxicity duality. Soriano-García (2004, 213 citations) reviews therapeutic agents.

Recent Advances

Study Misra et al. (2015, 303 citations) for redox-cancer links and Nogueira et al. (2021, 205 citations) for synthetic compound updates.

Core Methods

Core techniques: GPx mimetic catalysis assays (Alberto et al., 2010), redox cycling measurements (Misra et al., 2015), and structure-toxicity profiling via dose-response curves (Nogueira et al., 2021).

How PapersFlow Helps You Research Organoselenium Toxicology

Discover & Search

PapersFlow's Research Agent uses searchPapers and citationGraph to map high-citation works like Misra et al. (2015, 303 citations) on redox toxicity, then findSimilarPapers uncovers related ebselen toxicology from 250M+ OpenAlex papers. exaSearch drills into structure-toxicity datasets for Nogueira et al. (2021) updates.

Analyze & Verify

Analysis Agent applies readPaperContent to extract toxicity mechanisms from Azad and Tomar (2014), then verifyResponse with CoVe checks claims against GRADE grading for evidence strength in therapeutic indices. runPythonAnalysis processes dose-response curves from multiple papers using pandas for statistical LD50 comparisons and matplotlib visualizations.

Synthesize & Write

Synthesis Agent detects gaps in safe dosing data across ebselen papers, flagging contradictions in redox effects; Writing Agent uses latexEditText, latexSyncCitations for review drafts, and latexCompile for publication-ready manuscripts with exportMermaid diagrams of metabolism pathways.

Use Cases

"Extract dose-response data for ebselen hepatotoxicity from top papers"

Research Agent → searchPapers('ebselen hepatotoxicity') → Analysis Agent → readPaperContent(Azad 2014) → runPythonAnalysis(pandas curve fitting, matplotlib plots) → CSV export of LD50 stats.

"Draft LaTeX review on organoselenium SAR for toxicity"

Synthesis Agent → gap detection(Misra 2015, Nogueira 2021) → Writing Agent → latexEditText(structure-toxicity section) → latexSyncCitations → latexCompile(PDF review with figures).

"Find code for organoselenium QSAR toxicity models"

Research Agent → searchPapers('organoselenium QSAR toxicology') → Code Discovery → paperExtractUrls → paperFindGithubRepo → githubRepoInspect(RDKit scripts for prediction).

Automated Workflows

Deep Research workflow conducts systematic reviews of 50+ papers on ebselen toxicology: searchPapers → citationGraph → DeepScan(7-step verify with CoVe) → structured report with GRADE scores. Theorizer generates hypotheses on structure-toxicity from Misra et al. (2015) metabolism data: gap detection → theory synthesis → exportMermaid pathways. DeepScan analyzes Nogueira et al. (2021) updates with runPythonAnalysis for trend stats.

Try Doxa for Organoselenium Toxicology Research

Frequently Asked Questions

What defines organoselenium toxicology?

It covers toxicity profiles, metabolism, and structure-activity relationships of organoselenium compounds like ebselen, focusing on genotoxicity and safe dosing (Azad and Tomar, 2014).

What are main methods in this field?

Methods include in vitro redox assays, in vivo hepatotoxicity models, and GPx mimetic screening; Misra et al. (2015) detail concentration-dependent cell death assays.

What are key papers?

Top papers: Azad and Tomar (2014, 327 citations) on ebselen mechanisms; Misra et al. (2015, 303 citations) on redox toxicity; Nogueira et al. (2021, 205 citations) pharmacology update.

What are open problems?

Predicting metabolism-dependent toxicity and narrowing therapeutic windows remain unsolved; Parnham and Sies (2013) highlight gaps in ebselen clinical translation.